TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Bionordika AS
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
44,323
|
57,203
|
69,715 |
Financial expenses |
770
|
729
|
739 |
Earnings before taxes |
3,518
|
11,683
|
20,001 |
Total assets |
18,005
|
28,184
|
37,327 |
Current assets |
17,332
|
27,700
|
36,954 |
Current liabilities |
10,614
|
19,941
|
29,635 |
Equity capital |
7,272
|
8,040
|
7,691 |
- share capital |
101
|
108
|
105 |
Employees (average) | 10 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
40.4%
|
28.5%
|
20.6% |
Turnover per employee | 6,972 | ||
Profit as a percentage of turnover |
7.9%
|
20.4%
|
28.7% |
Return on assets (ROA) |
23.8%
|
44.0%
|
55.6% |
Current ratio |
163.3%
|
138.9%
|
124.7% |
Return on equity (ROE) |
48.4%
|
145.3%
|
260.1% |
Change turnover |
-9,090
|
-14,673
|
-6,285 |
Change turnover % |
-17%
|
-20%
|
-8% |
Chg. No. of employees | -3 | ||
Chg. No. of employees % | -23% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.